Introduction
Rapid detection of antigen refers to the application of nucleocapsid protein-specific antibodies in the direct detection of pathogens in a sample, the result can be used as direct evidence of early identification of infection the pathogen or not, detecting a rapid (15min), convenient operation of the detection method. Applicable scenarios: Weak nucleic acid detection capabilities, insufficient detection capabilities, and places where urgent results are needed. It has been widely used in Europe, America, Asia, Africa and other regions, and together with nucleic acid testing has become an important detec;tion method for the prevention and control of the.

​​​

Features:
* The use of nasopharyngeal swab.
* Rapid detection :15 minutes out of the results.
* High accuracy
* Easy to use.

 

Contact Rachel to see the catalog and real pictures

WhatsApp/Phone: 0086 15153125072

Email: sales146@biobase.world

Advantage:
antigen detection can directly detect whether the human body contains, which can be detected at the early stage of virus infection. It is fast, accurate, and requires less equipment and personnel. Using double antibody sandwich method and using two antigen specific antibodies to identify and combine different epitopes of a target antigen, it can greatly reduce the number of cross reactions. So as to improve its specificity.

Sample collection:

Sample testing:

The results of judgment:
Positive: T-line and C-line present within 15-20 minutes after sample addition.
Negative: only C-line, no T-line, occurs within 15-20 minutes after dropping the sample.
Invalid: As long as there is no line C, this test card is invalid. Please use another test card to retest.


The results are summarized in the following table. The RT-PCR cycle threshold (Ct) is the relevant signal value. Lower Ct value indicate higher viral load. The sensitivity was calculated for the different Ct value range (Ct value≤33 and Ct value≤37).
 

Antigen	RT-PCR (Ct value≤33)
	Positive	Negative
Positive	152	3
Negative	5	601
Total	157	604

 

Sensitivity (Ct≤33): 96.8% (152/157), (95%CI: 92.8%~98.6%)
Specificity: 99.5% (601/604), (95%CI: 98.6%~99.7%)
Accuracy: 98.9%((152+601)/761), (95%CI: 98.2%~99.5%)

 

 

Product Name	Main composition	Testing time	Dimensions	Net Weight	Kit Size	Package Size	Gross Weight
Antigen Test Kit(Colloidal Gold)	Test card, Sample extraction buffer, Nasal swab or Throat swab	15-20min	205*120*75mm	0.3kg	20T/box 50 boxes/carton	620*430*400mm	17kg

Shandong Boke Health Industry Co., LTD (hereinafter referred to as Brocade Group), under the brand BIOBASE, is an investment and asset management capital operation institution with Brocade Holding Group Co., LTD as the core enterprise approved by the State Administration for Industry and Commerce. It is a company with the life and health industry as the core.Business covers biomedicine, e-commerce, intelligent manufacturing, incubation services and other industries of the group company, headquartered in the spring city of Jinan.
The group has more than 5,000 employees, 22 production and office parks, covering a total area of 932,900 square meters, and established overseas incubation bases in Silicon Valley, Dubai, India, Algeria, Singapore and other places.
The group is mainly engaged in medical equipment and experimental equipment products, with more than 200 high-tech products. Biosafety cabinet and other products have passed the CE, EN, NSF, FDA and other authoritative certification, with more than 430 registration certificates and more than 300 authorized patents.
At present, the company has been identified as quasi-unicorn enterprise of Shandong Province, Gazelle Demonstration Enterprise of Shandong Province, Technological Innovation Demonstration Enterprise of Shandong Province, etc., and has been included in the first batch of Top 100 Enterprises of High-tech Industry innovation ability of Shandong Province (" Top 100 Enterprises "), and has been listed on the list of top 1000 Enterprises of Chinese Enterprise Innovation Ability for two consecutive years.Boke Group has invested in the establishment of provincial enterprise technology center, provincial industrial design center, provincial engineering technology research center, provincial postdoctoral innovation practice base and other R&D platforms, and has undertaken a number of national, provincial and municipal scientific research projects.